Loring Wolcott & Coolidge Fiduciary Advisors LLP Novo Nordisk A S Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.3 Billion
- Q1 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 121,030 shares of NVO stock, worth $8.68 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
121,030
Previous 113,688
6.46%
Holding current value
$8.68 Million
Previous $9.78 Million
14.06%
% of portfolio
0.08%
Previous 0.09%
Shares
27 transactions
Others Institutions Holding NVO
# of Institutions
1,759Shares Held
339MCall Options Held
11.4MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.35 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.06 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$888 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$883 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$851 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $162B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...